nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2C8—Ifosfamide—testicular cancer	0.135	0.207	CbGbCtD
Almotriptan—CYP2C19—Ifosfamide—testicular cancer	0.114	0.174	CbGbCtD
Almotriptan—CYP2E1—Etoposide—testicular cancer	0.0866	0.133	CbGbCtD
Almotriptan—CYP2C8—Etoposide—testicular cancer	0.0647	0.0992	CbGbCtD
Almotriptan—CYP3A4—Ifosfamide—testicular cancer	0.0549	0.0841	CbGbCtD
Almotriptan—CYP1A2—Etoposide—testicular cancer	0.0501	0.0768	CbGbCtD
Almotriptan—CYP2D6—Vinblastine—testicular cancer	0.0458	0.0702	CbGbCtD
Almotriptan—CYP3A4—Vinblastine—testicular cancer	0.0291	0.0446	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—testicular cancer	0.0282	0.0431	CbGbCtD
Almotriptan—CYP3A4—Etoposide—testicular cancer	0.0263	0.0402	CbGbCtD
Almotriptan—CYP3A4—Doxorubicin—testicular cancer	0.0179	0.0274	CbGbCtD
Almotriptan—Asthenia—Dactinomycin—testicular cancer	0.000596	0.00172	CcSEcCtD
Almotriptan—Paraesthesia—Cisplatin—testicular cancer	0.000589	0.0017	CcSEcCtD
Almotriptan—Tachycardia—Etoposide—testicular cancer	0.000587	0.00169	CcSEcCtD
Almotriptan—Dyspnoea—Cisplatin—testicular cancer	0.000585	0.00168	CcSEcCtD
Almotriptan—Skin disorder—Etoposide—testicular cancer	0.000584	0.00168	CcSEcCtD
Almotriptan—Hyperhidrosis—Etoposide—testicular cancer	0.000581	0.00167	CcSEcCtD
Almotriptan—Abdominal pain upper—Doxorubicin—testicular cancer	0.000579	0.00167	CcSEcCtD
Almotriptan—Photosensitivity reaction—Methotrexate—testicular cancer	0.000578	0.00166	CcSEcCtD
Almotriptan—Angina pectoris—Epirubicin—testicular cancer	0.000577	0.00166	CcSEcCtD
Almotriptan—Breast disorder—Doxorubicin—testicular cancer	0.000573	0.00165	CcSEcCtD
Almotriptan—Bronchitis—Epirubicin—testicular cancer	0.00057	0.00164	CcSEcCtD
Almotriptan—Diarrhoea—Dactinomycin—testicular cancer	0.000568	0.00164	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000566	0.00163	CcSEcCtD
Almotriptan—Vomiting—Bleomycin—testicular cancer	0.000566	0.00163	CcSEcCtD
Almotriptan—Rash—Bleomycin—testicular cancer	0.000561	0.00162	CcSEcCtD
Almotriptan—Gastritis—Doxorubicin—testicular cancer	0.000561	0.00162	CcSEcCtD
Almotriptan—Pain—Cisplatin—testicular cancer	0.000561	0.00162	CcSEcCtD
Almotriptan—Dermatitis—Bleomycin—testicular cancer	0.000561	0.00162	CcSEcCtD
Almotriptan—Hypersensitivity—Ifosfamide—testicular cancer	0.000561	0.00161	CcSEcCtD
Almotriptan—Muscular weakness—Doxorubicin—testicular cancer	0.000559	0.00161	CcSEcCtD
Almotriptan—Conjunctivitis—Methotrexate—testicular cancer	0.000549	0.00158	CcSEcCtD
Almotriptan—Asthenia—Ifosfamide—testicular cancer	0.000546	0.00157	CcSEcCtD
Almotriptan—Photosensitivity reaction—Epirubicin—testicular cancer	0.000541	0.00156	CcSEcCtD
Almotriptan—Feeling abnormal—Cisplatin—testicular cancer	0.000541	0.00156	CcSEcCtD
Almotriptan—Paraesthesia—Etoposide—testicular cancer	0.00054	0.00155	CcSEcCtD
Almotriptan—Pruritus—Ifosfamide—testicular cancer	0.000538	0.00155	CcSEcCtD
Almotriptan—Dyspnoea—Etoposide—testicular cancer	0.000536	0.00154	CcSEcCtD
Almotriptan—Hyperglycaemia—Epirubicin—testicular cancer	0.000534	0.00154	CcSEcCtD
Almotriptan—Somnolence—Etoposide—testicular cancer	0.000534	0.00154	CcSEcCtD
Almotriptan—Angina pectoris—Doxorubicin—testicular cancer	0.000534	0.00154	CcSEcCtD
Almotriptan—Epistaxis—Methotrexate—testicular cancer	0.000532	0.00153	CcSEcCtD
Almotriptan—Nausea—Bleomycin—testicular cancer	0.000529	0.00152	CcSEcCtD
Almotriptan—Vomiting—Dactinomycin—testicular cancer	0.000528	0.00152	CcSEcCtD
Almotriptan—Bronchitis—Doxorubicin—testicular cancer	0.000527	0.00152	CcSEcCtD
Almotriptan—Rash—Dactinomycin—testicular cancer	0.000524	0.00151	CcSEcCtD
Almotriptan—Diarrhoea—Ifosfamide—testicular cancer	0.000521	0.0015	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Etoposide—testicular cancer	0.000519	0.00149	CcSEcCtD
Almotriptan—Body temperature increased—Cisplatin—testicular cancer	0.000519	0.00149	CcSEcCtD
Almotriptan—Fatigue—Etoposide—testicular cancer	0.000518	0.00149	CcSEcCtD
Almotriptan—Neuropathy peripheral—Epirubicin—testicular cancer	0.000518	0.00149	CcSEcCtD
Almotriptan—Pain—Etoposide—testicular cancer	0.000514	0.00148	CcSEcCtD
Almotriptan—Conjunctivitis—Epirubicin—testicular cancer	0.000513	0.00148	CcSEcCtD
Almotriptan—Dizziness—Ifosfamide—testicular cancer	0.000503	0.00145	CcSEcCtD
Almotriptan—Pharyngitis—Methotrexate—testicular cancer	0.000503	0.00145	CcSEcCtD
Almotriptan—Photosensitivity reaction—Doxorubicin—testicular cancer	0.0005	0.00144	CcSEcCtD
Almotriptan—Epistaxis—Epirubicin—testicular cancer	0.000498	0.00143	CcSEcCtD
Almotriptan—Sinusitis—Epirubicin—testicular cancer	0.000496	0.00143	CcSEcCtD
Almotriptan—Feeling abnormal—Etoposide—testicular cancer	0.000495	0.00143	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—testicular cancer	0.000494	0.00142	CcSEcCtD
Almotriptan—Nausea—Dactinomycin—testicular cancer	0.000493	0.00142	CcSEcCtD
Almotriptan—Gastrointestinal pain—Etoposide—testicular cancer	0.000491	0.00142	CcSEcCtD
Almotriptan—Visual impairment—Methotrexate—testicular cancer	0.000488	0.00141	CcSEcCtD
Almotriptan—Vomiting—Ifosfamide—testicular cancer	0.000484	0.00139	CcSEcCtD
Almotriptan—Hypersensitivity—Cisplatin—testicular cancer	0.000483	0.00139	CcSEcCtD
Almotriptan—Rash—Ifosfamide—testicular cancer	0.00048	0.00138	CcSEcCtD
Almotriptan—Dermatitis—Ifosfamide—testicular cancer	0.000479	0.00138	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000479	0.00138	CcSEcCtD
Almotriptan—Rhinitis—Epirubicin—testicular cancer	0.000475	0.00137	CcSEcCtD
Almotriptan—Abdominal pain—Etoposide—testicular cancer	0.000475	0.00137	CcSEcCtD
Almotriptan—Body temperature increased—Etoposide—testicular cancer	0.000475	0.00137	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—testicular cancer	0.000475	0.00137	CcSEcCtD
Almotriptan—Eye disorder—Methotrexate—testicular cancer	0.000474	0.00136	CcSEcCtD
Almotriptan—Tinnitus—Methotrexate—testicular cancer	0.000472	0.00136	CcSEcCtD
Almotriptan—Hypoaesthesia—Epirubicin—testicular cancer	0.000472	0.00136	CcSEcCtD
Almotriptan—Asthenia—Cisplatin—testicular cancer	0.000471	0.00136	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—testicular cancer	0.000471	0.00136	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—testicular cancer	0.00047	0.00135	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—testicular cancer	0.000461	0.00133	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—testicular cancer	0.000459	0.00132	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—testicular cancer	0.000458	0.00132	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—testicular cancer	0.000457	0.00132	CcSEcCtD
Almotriptan—Chills—Methotrexate—testicular cancer	0.000455	0.00131	CcSEcCtD
Almotriptan—Nausea—Ifosfamide—testicular cancer	0.000452	0.0013	CcSEcCtD
Almotriptan—Diarrhoea—Cisplatin—testicular cancer	0.000449	0.00129	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—testicular cancer	0.000444	0.00128	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—testicular cancer	0.000443	0.00128	CcSEcCtD
Almotriptan—Hypersensitivity—Etoposide—testicular cancer	0.000443	0.00128	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—testicular cancer	0.000442	0.00127	CcSEcCtD
Almotriptan—Erythema—Methotrexate—testicular cancer	0.000441	0.00127	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—testicular cancer	0.00044	0.00127	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—testicular cancer	0.00044	0.00127	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—testicular cancer	0.000437	0.00126	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—testicular cancer	0.000435	0.00125	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—testicular cancer	0.000432	0.00124	CcSEcCtD
Almotriptan—Asthenia—Etoposide—testicular cancer	0.000431	0.00124	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—testicular cancer	0.000428	0.00123	CcSEcCtD
Almotriptan—Back pain—Methotrexate—testicular cancer	0.000427	0.00123	CcSEcCtD
Almotriptan—Chills—Epirubicin—testicular cancer	0.000425	0.00123	CcSEcCtD
Almotriptan—Pruritus—Etoposide—testicular cancer	0.000425	0.00122	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—testicular cancer	0.000423	0.00122	CcSEcCtD
Almotriptan—Vomiting—Cisplatin—testicular cancer	0.000417	0.0012	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—testicular cancer	0.000416	0.0012	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—testicular cancer	0.000415	0.0012	CcSEcCtD
Almotriptan—Rash—Cisplatin—testicular cancer	0.000414	0.00119	CcSEcCtD
Almotriptan—Dermatitis—Cisplatin—testicular cancer	0.000413	0.00119	CcSEcCtD
Almotriptan—Erythema—Epirubicin—testicular cancer	0.000413	0.00119	CcSEcCtD
Almotriptan—Diarrhoea—Etoposide—testicular cancer	0.000411	0.00118	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—testicular cancer	0.00041	0.00118	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—testicular cancer	0.000409	0.00118	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—testicular cancer	0.000409	0.00118	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—testicular cancer	0.000407	0.00117	CcSEcCtD
Almotriptan—Tension—Epirubicin—testicular cancer	0.000405	0.00117	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—testicular cancer	0.000404	0.00116	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—testicular cancer	0.000401	0.00115	CcSEcCtD
Almotriptan—Back pain—Epirubicin—testicular cancer	0.000399	0.00115	CcSEcCtD
Almotriptan—Malaise—Methotrexate—testicular cancer	0.000398	0.00115	CcSEcCtD
Almotriptan—Dizziness—Etoposide—testicular cancer	0.000397	0.00114	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—testicular cancer	0.000396	0.00114	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—testicular cancer	0.000396	0.00114	CcSEcCtD
Almotriptan—Chills—Doxorubicin—testicular cancer	0.000394	0.00113	CcSEcCtD
Almotriptan—Nausea—Cisplatin—testicular cancer	0.00039	0.00112	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—testicular cancer	0.000389	0.00112	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—testicular cancer	0.000384	0.00111	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—testicular cancer	0.000383	0.0011	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—testicular cancer	0.000382	0.0011	CcSEcCtD
Almotriptan—Vomiting—Etoposide—testicular cancer	0.000382	0.0011	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—testicular cancer	0.000382	0.0011	CcSEcCtD
Almotriptan—Agitation—Epirubicin—testicular cancer	0.000379	0.00109	CcSEcCtD
Almotriptan—Rash—Etoposide—testicular cancer	0.000379	0.00109	CcSEcCtD
Almotriptan—Dermatitis—Etoposide—testicular cancer	0.000379	0.00109	CcSEcCtD
Almotriptan—Headache—Etoposide—testicular cancer	0.000377	0.00108	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—testicular cancer	0.000376	0.00108	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—testicular cancer	0.000376	0.00108	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—testicular cancer	0.000376	0.00108	CcSEcCtD
Almotriptan—Tension—Doxorubicin—testicular cancer	0.000375	0.00108	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—testicular cancer	0.000374	0.00108	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000373	0.00107	CcSEcCtD
Almotriptan—Malaise—Epirubicin—testicular cancer	0.000372	0.00107	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—testicular cancer	0.000371	0.00107	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—testicular cancer	0.000371	0.00107	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—testicular cancer	0.000371	0.00107	CcSEcCtD
Almotriptan—Syncope—Epirubicin—testicular cancer	0.00037	0.00107	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—testicular cancer	0.000369	0.00106	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—testicular cancer	0.000365	0.00105	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—testicular cancer	0.000363	0.00105	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—testicular cancer	0.000363	0.00104	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—testicular cancer	0.00036	0.00104	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—testicular cancer	0.00036	0.00104	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—testicular cancer	0.000358	0.00103	CcSEcCtD
Almotriptan—Nausea—Etoposide—testicular cancer	0.000357	0.00103	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—testicular cancer	0.000356	0.00103	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—testicular cancer	0.000354	0.00102	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—testicular cancer	0.000353	0.00102	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—testicular cancer	0.000351	0.00101	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—testicular cancer	0.000351	0.00101	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—testicular cancer	0.000351	0.00101	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—testicular cancer	0.000351	0.00101	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—testicular cancer	0.00035	0.00101	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—testicular cancer	0.00035	0.00101	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000349	0.00101	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—testicular cancer	0.000348	0.001	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—testicular cancer	0.000347	0.001	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—testicular cancer	0.000344	0.000992	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—testicular cancer	0.000344	0.00099	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—testicular cancer	0.000343	0.000988	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—testicular cancer	0.000343	0.000986	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—testicular cancer	0.00034	0.000978	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—testicular cancer	0.000338	0.000972	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—testicular cancer	0.000337	0.00097	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—testicular cancer	0.000336	0.000967	CcSEcCtD
Almotriptan—Shock—Epirubicin—testicular cancer	0.000331	0.000955	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—testicular cancer	0.000331	0.000953	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—testicular cancer	0.00033	0.000951	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—testicular cancer	0.00033	0.00095	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—testicular cancer	0.000329	0.000947	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000328	0.000945	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—testicular cancer	0.000327	0.000942	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—testicular cancer	0.000326	0.000938	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—testicular cancer	0.000326	0.000938	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—testicular cancer	0.000325	0.000936	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—testicular cancer	0.000325	0.000936	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—testicular cancer	0.000325	0.000936	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—testicular cancer	0.000324	0.000933	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—testicular cancer	0.000323	0.000931	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000323	0.00093	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—testicular cancer	0.000321	0.000925	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—testicular cancer	0.000321	0.000924	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—testicular cancer	0.00032	0.000922	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—testicular cancer	0.000318	0.000916	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—testicular cancer	0.000317	0.000913	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—testicular cancer	0.000314	0.000905	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—testicular cancer	0.000312	0.000898	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000311	0.000895	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—testicular cancer	0.00031	0.000894	CcSEcCtD
Almotriptan—Pain—Methotrexate—testicular cancer	0.000308	0.000887	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000307	0.000884	CcSEcCtD
Almotriptan—Shock—Doxorubicin—testicular cancer	0.000307	0.000883	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—testicular cancer	0.000306	0.00088	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—testicular cancer	0.000305	0.000878	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—testicular cancer	0.000304	0.000876	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—testicular cancer	0.000303	0.000872	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—testicular cancer	0.000303	0.000871	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—testicular cancer	0.000301	0.000868	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—testicular cancer	0.0003	0.000865	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—testicular cancer	0.0003	0.000863	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—testicular cancer	0.000297	0.000854	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—testicular cancer	0.000297	0.000854	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—testicular cancer	0.000294	0.000848	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000291	0.000838	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—testicular cancer	0.00029	0.000836	CcSEcCtD
Almotriptan—Pain—Epirubicin—testicular cancer	0.000288	0.00083	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—testicular cancer	0.000285	0.00082	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—testicular cancer	0.000285	0.00082	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000284	0.000818	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—testicular cancer	0.000282	0.000812	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—testicular cancer	0.00028	0.000806	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—testicular cancer	0.000278	0.0008	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—testicular cancer	0.000278	0.000799	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—testicular cancer	0.000277	0.000798	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—testicular cancer	0.000275	0.000793	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—testicular cancer	0.000274	0.00079	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000269	0.000775	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—testicular cancer	0.000269	0.000774	CcSEcCtD
Almotriptan—Pain—Doxorubicin—testicular cancer	0.000267	0.000768	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—testicular cancer	0.000266	0.000767	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—testicular cancer	0.000266	0.000767	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—testicular cancer	0.000265	0.000764	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—testicular cancer	0.000258	0.000744	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—testicular cancer	0.000257	0.00074	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000255	0.000734	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—testicular cancer	0.000255	0.000733	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—testicular cancer	0.000248	0.000715	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—testicular cancer	0.000246	0.00071	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—testicular cancer	0.000246	0.00071	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—testicular cancer	0.000246	0.000709	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—testicular cancer	0.000242	0.000696	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—testicular cancer	0.000238	0.000686	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—testicular cancer	0.000238	0.000686	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—testicular cancer	0.000231	0.000664	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—testicular cancer	0.00023	0.000661	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—testicular cancer	0.000229	0.000659	CcSEcCtD
Almotriptan—Rash—Methotrexate—testicular cancer	0.000227	0.000654	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—testicular cancer	0.000227	0.000653	CcSEcCtD
Almotriptan—Headache—Methotrexate—testicular cancer	0.000226	0.000649	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—testicular cancer	0.000224	0.000644	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—testicular cancer	0.000223	0.000642	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—testicular cancer	0.000221	0.000635	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—testicular cancer	0.000214	0.000617	CcSEcCtD
Almotriptan—Nausea—Methotrexate—testicular cancer	0.000214	0.000616	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—testicular cancer	0.000213	0.000614	CcSEcCtD
Almotriptan—Rash—Epirubicin—testicular cancer	0.000212	0.000612	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—testicular cancer	0.000212	0.000611	CcSEcCtD
Almotriptan—Headache—Epirubicin—testicular cancer	0.000211	0.000608	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—testicular cancer	0.000206	0.000594	CcSEcCtD
Almotriptan—Nausea—Epirubicin—testicular cancer	0.0002	0.000576	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—testicular cancer	0.000198	0.000571	CcSEcCtD
Almotriptan—Rash—Doxorubicin—testicular cancer	0.000197	0.000566	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—testicular cancer	0.000196	0.000565	CcSEcCtD
Almotriptan—Headache—Doxorubicin—testicular cancer	0.000195	0.000562	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—testicular cancer	0.000185	0.000533	CcSEcCtD
